CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition | +438,502 | 438,502 | ||
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +16,505 | 16,505 | ||
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +82,349 | 82,349 | ||
| 2020-09-14 | Rauch Lee M. President & CEO | Grant or award · Stock Option (right to buy) | +900,000 | 900,000 | ||
| 2020-09-13 | Rauch Lee M. President & CEO | Grant or award · Stock Option (right to buy) | +900,000 | 900,000 | ||
| 2020-05-21 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-05-21 | TURNER JOSEPH L Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-05-21 | Morris Arlene Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-05-21 | KOCH KEVIN Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-05-21 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-05-21 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2020-03-13 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise | +11,249 | $0.57 | $6K | 48,829 |
| 2020-03-13 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise · Stock Option (right to buy) | −11,249 | 0 | ||
| 2020-02-12 | Escolar Diana Chief Medical Officer | Grant or award · Stock Option (right to buy) | +270,000 | 270,000 | ||
| 2020-02-12 | Leverone Jason A. CFO, Treasurer & Secretary | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2020-02-12 | Marshall William Stuart President & CEO | Grant or award · Stock Option (right to buy) | +464,000 | 464,000 | ||
| 2019-08-23 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise | +3,093 | $0.57 | $2K | 36,330 |
| 2019-08-23 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise · Stock Option (right to buy) | −3,093 | 0 | ||
| 2019-06-19 | TURNER JOSEPH L Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-19 | Morris Arlene Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 |
Page 11 of 16 · 309 trades